Ventripoint Diagnostics (5V7) Stock Overview
A medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
5V7 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Ventripoint Diagnostics Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.056 |
| 52 Week High | CA$0.094 |
| 52 Week Low | CA$0.039 |
| Beta | -0.062 |
| 1 Month Change | -9.68% |
| 3 Month Change | -21.13% |
| 1 Year Change | -32.12% |
| 3 Year Change | -38.12% |
| 5 Year Change | -83.43% |
| Change since IPO | -70.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| 5V7 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 7.7% | -8.0% | -2.8% |
| 1Y | -32.1% | -25.8% | 3.7% |
Return vs Industry: 5V7 underperformed the German Medical Equipment industry which returned -23.2% over the past year.
Return vs Market: 5V7 underperformed the German Market which returned 4.9% over the past year.
Price Volatility
| 5V7 volatility | |
|---|---|
| 5V7 Average Weekly Movement | 12.6% |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in DE Market | 13.8% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: 5V7's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 5V7's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Hugh MacNaught | ventripoint.com |
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. It also provides VMS+ software, a 2D and 3D ultrasound models.
Ventripoint Diagnostics Ltd. Fundamentals Summary
| 5V7 fundamental statistics | |
|---|---|
| Market cap | €12.29m |
| Earnings (TTM) | -€2.54m |
| Revenue (TTM) | €109.67k |
Is 5V7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5V7 income statement (TTM) | |
|---|---|
| Revenue | CA$175.62k |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$175.62k |
| Other Expenses | CA$4.24m |
| Earnings | -CA$4.06m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.022 |
| Gross Margin | 100.00% |
| Net Profit Margin | -2,311.82% |
| Debt/Equity Ratio | -46.8% |
How did 5V7 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/24 14:18 |
| End of Day Share Price | 2026/04/24 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ventripoint Diagnostics Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.